 Patients will thereafter be randomly assigned to one of two groups: olanzapine lithium, or chlorpromazine lithium. The raters research assistant and one psychiatrist in charge of the rating of the side effects will be blind to the randomisation process and treatment conditions during the first 8 weeks of the trial. 